![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
EASL Policy Statement on the coexistence of NAFLD and ARLD (Patient Forum 2020) (EASL - Home of Hepatology) View |
![]() |
Andrew Moon, MD, MPH: Opioid Use High in NAFLD Patients (HCPLive) View |
![]() |
Crucial updates on Fatty Liver disease - EASL 2023 - steatotic liver disease, MASLD, and MetALD (Edusurg Clinics) View |
![]() |
Diabesity, and cardiovascular risk: How to manage them in patients with NAFLD (Marina Maevskaia) (PRO.MED.CS Praha a.s.) View |
![]() |
Non-invasive assessment of liver fibrosis and steatosis by Dr. G. Ferraioli, MD (FUJIFILM Healthcare Europe) View |
![]() |
Session 3: Dos and Don'ts in Hepatology: Don't Ignore Asymptomatic Transaminitis - Mona Amin (Kasr Al-Ainy EHGC) View |
![]() |
() View |
![]() |
() View |
![]() |
() View |
![]() |
() View |